SECUKINUMAB PROVIDES SUSTAINED REDUCTION IN FATIGUE IN PATIENTS WITH ANKYLOSING SPONDYLITIS THROUGH THREE YEARS: LONG-TERM RESULTS OF TWO RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDIES

被引：0

作者：

Marzo-Ortega, Helena ^{[1
,2
]}

Kvien, Tore K. ^{[3
]}

Deodhar, Atul A. ^{[4
]}

Gossec, Laure ^{[5
,6
]}

Conaghan, Philip G. ^{[1
,2
]}

Strand, Vibeke ^{[7
]}

Ostergaard, Mikkel ^{[8
]}

Williams, Nicole ^{[9
]}

Porter, Brian ^{[10
]}

Gandi, Kunal ^{[11
]}

Jugl, Steffen ^{[12
]}

机构：

[1] Leeds Teaching Hosp Trust, NIHR Leeds Biomed Res Ctr, Leeds, W Yorkshire, England

[2] Univ Leeds, Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England

[3] Diakonhjemmet Hosp, Rheumatol, Oslo, Norway

[4] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA

[5] UPMC Univ Paris 06, Rheumatol, Paris, France

[6] Hop La Pitie Salpetriere, Paris, France

[7] Stanford Univ, Sch Med, Immunol & Rheumatol, Palo Alto, CA 94304 USA

[8] Rigshosp, Copenhagen Ctr Arthrit Res COPECARE, Glostrup, Denmark

[9] RTI Hlth Solut, Patient Ctr Outcomes Assessment, Durham, NC USA

[10] Novartis Pharmaceut, Immunol & Dermatol, E Hanover, NJ USA

[11] Novartis Pharmaceut, Worldwide Med Affairs Immunol & Dermatol, E Hanover, NJ USA

[12] Novartis Pharma AG, Immunol & Dermatol, Basel, Switzerland

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

176

引用

页数：2